Tweet #1100704528469508096
P10063 – Phase1 & Phase2 studies evaluating the MoA, safety, efficacy of Clascoterone in Androgenetic Alopecia
P105…
https://twitter.com/i/web/status/1100704528469508096
P10063 – Phase1 & Phase2 studies evaluating the MoA, safety, efficacy of Clascoterone in Androgenetic Alopecia
P105…
https://twitter.com/i/web/status/1100704528469508096